Volume 3, 2022



Stoyan Hristov
Pages: 119-127

ABSTRACT: Traditionally, anatomical total shoulder arthroplasty has been used to treat the shoulder joint with end-stage glenohumeral osteoarthritis and an intact rotator cuff. Shoulder hemiarthroplasty was choice of treatment for patients without a rotator cuff or with rotator cuff tear arthropathy, assuring unpredictable pain relief and questionable improvement in range of motion or function. The number of shoulder replacements performed each year continues to increase, and the need for revision replacements has grown accordingly. The outcome of a revision shoulder procedures may influence which primary prosthesis is selected and the appropriate timing of primary arthroplasty. The demand for shoulder replacements continues to rise last decades according to broaden indications for the surgery and technical innovation. Aging population contribute to an increase in the number of replacements performed each year. Innitially, the reverse total shoulder arthroplasty (RTSA) has been introduced in 1987 by Grammont with purpose to treat rotator cuff tear arthropathy. Since US FDA (Food and Drug Administration) approval in 2004 the number of RTSAs performed annually increased dramatically. According to Kim in 2007 in the USA approximately 10 000 RTSAs were performed, which is a fivefold increase over 2004. The goal of our study is to analyze tendency of this surgical procedure and to compare our arthroplasty trends to the literature data.


Keywords: shoulder arthroplasty, proximal humeral fracture, reverse total shoulder arthroplasty


Download full text as PDF file



Back to the contents of the volume